search
Back to results

CGM - Reimagine Primary Care

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Dexcom G6
Contour NextOne
Sponsored by
Intermountain Health Care, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Continuous Glucose Monitor (CGM), Dexcom G6

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 1 or type 2 diabetes mellitus with a HbA1c ≥6.5%
  • Patients that are currently managing their glucose levels for diabetes with a glucose meter (or will be prescribed one by their healthcare provider)
  • Patients that are treated within the four Reimagine Primary Care clinics (Cottonwood Family Medicine, Cottonwood Senior, Avenues Internal Medicine, and Holladay Internal Medicine). • Patients 18-80 years of age

Exclusion Criteria:

  • Patients that are not managing their glucose levels for diabetes (and not advised to use a glucose monitor by their physician)
  • Patients that are not treated within the four Reimagine Primary Care clinics
  • Patients less than 18 years of age, and 81 years of age and older
  • Patients with a diagnosis of dementia
  • If the patient is currently using a Continuous Glucose Monitor
  • Patients with previous hospitalization for hypoglycemia within the last 18 months
  • No access to a mobile phone to download the Dexcom or Contour Next applications
  • Patients who are pregnant or planning to become pregnant over the course of their six-month participation

Sites / Locations

  • Holladay Internal Medicine
  • Intermountain Cottonwood Family Practice
  • Intermountain Senior Clinic
  • Avenues Internal Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Dexcom G6 (Intervention Group)

Contour NextOne (Standard of Care) Glucometer

Arm Description

• Intervention group: CGM using a Dexcom G6 to measure glycosylated hemoglobin levels every five minutes. Patients will be asked to download the Dexcom G6 and Clarity applications (to have access to their real-time data) and be given a link to complete an exit survey in REDCap near the end of their study participation. Data will be sent via Bluetooth and then exported by the Intermountain research team into a Tableau (or similar) dashboard for data analysis/comparison

• Control group: A standard finger-prick protocol that will require patients to continue with their daily fingerprick regimen established by their physician. This group will be given a Contour Next One meter to ensure that each patient is receiving the same level of accuracy by the same device. A review by Ekhlaspour et al of 17 glucose meters demonstrated wide variability, with only two devices achieving the 2013 ISO standard (with the most accurate being the Contour Next). Patients in the control group will be asked to download the Contour Next application which will send data via Bluetooth similar to above. Data will be aggregated, and protected health information removed prior to analysis (by Intermountain Healthcare and Savvysherpa). At the end of the study, patients will be asked to complete a short survey in REDCap about their willingness to participate in future studies.

Outcomes

Primary Outcome Measures

HbA1c Variation
Coefficient of variation in HbA1c levels before, during and end of study completion.
HbA1c Range
Variation of range in HbA1c levels before, during and end of study completion.

Secondary Outcome Measures

Current Diabetes Standards
Current HEDIS performance on diabetes and behavioral health measures.
Behavioral Changes
Subjects will complete a self reported survey related to behavioral changes at end of study to assess self empowered behavioral changes after using the devices (e.g. feeling more empowered to self-manage care, engaged with changing healthcare behaviors, and patient perceptions of the technology).
Hypoglycemic Events
Frequency of hypoglycemic events during the study.
Healthcare Utilization
Healthcare utilization per count of inpatient/outpatient visits.
Glycemic Variability
Glycemic variability per mean amplitude of glycemic excursion (MAGE)
Emergency Room Visits
Emergency department visits per 1000 rate, overall and for patients with diabetes, and hospitalization per 1000 rate related to.
Healthcare Cost
Cost per patient of healthcare for Emergency Room visits, blood draws, inpatient/outpatient services, medications etc.

Full Information

First Posted
May 21, 2020
Last Updated
May 28, 2020
Sponsor
Intermountain Health Care, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04413578
Brief Title
CGM - Reimagine Primary Care
Official Title
Assessing the Feasibility of Continuous Glucose Monitoring in Reimagine Primary Care Clinics
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
December 1, 2018 (Actual)
Primary Completion Date
November 28, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Intermountain Health Care, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes

5. Study Description

Brief Summary
To assess the impact of continuous glucose monitoring versus standard of care (e.g. a finger-prick protocol using a glucometer) on clinical outcomes, healthcare utilization, and cost in patients with type I or II diabetes treated within the Reimagine Primary Care clinics.
Detailed Description
This is a parallel randomized controlled trial. Eligible patients who consent will be randomized to one of two groups: (1) the intervention group who will be given a Dexcom G6 for CGM, or (2) the control group who will follow their current standard finger-prick protocol via a provided Contour Next ONE glucometer. The CGM group must download the Dexcom G6 and Clarity mobile apps for data capture, whereas the standard of care group will use the Contour Next mobile app for their respective readings. The Dexcom G6 captures real-time, dynamic glucose data every five minutes. Devices used in this study are FDA approved and commercially available.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Continuous Glucose Monitor (CGM), Dexcom G6

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Parallel Randomized Control Trial
Masking
None (Open Label)
Masking Description
Patients were either randomized to the Dexcom G6 Device or the Contour NextOne a Standard of Care glucometer. Both subjects knew what they received after they were randomized.
Allocation
Randomized
Enrollment
101 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dexcom G6 (Intervention Group)
Arm Type
Experimental
Arm Description
• Intervention group: CGM using a Dexcom G6 to measure glycosylated hemoglobin levels every five minutes. Patients will be asked to download the Dexcom G6 and Clarity applications (to have access to their real-time data) and be given a link to complete an exit survey in REDCap near the end of their study participation. Data will be sent via Bluetooth and then exported by the Intermountain research team into a Tableau (or similar) dashboard for data analysis/comparison
Arm Title
Contour NextOne (Standard of Care) Glucometer
Arm Type
Placebo Comparator
Arm Description
• Control group: A standard finger-prick protocol that will require patients to continue with their daily fingerprick regimen established by their physician. This group will be given a Contour Next One meter to ensure that each patient is receiving the same level of accuracy by the same device. A review by Ekhlaspour et al of 17 glucose meters demonstrated wide variability, with only two devices achieving the 2013 ISO standard (with the most accurate being the Contour Next). Patients in the control group will be asked to download the Contour Next application which will send data via Bluetooth similar to above. Data will be aggregated, and protected health information removed prior to analysis (by Intermountain Healthcare and Savvysherpa). At the end of the study, patients will be asked to complete a short survey in REDCap about their willingness to participate in future studies.
Intervention Type
Device
Intervention Name(s)
Dexcom G6
Intervention Description
Continuous Glucose Monitor that, after applied, sends continuous glucose readings to to the patient's smartphone every 5 minutes. This allows the patients to receive more readings over a 24 hour period versus standard of care glucometer finger sticks.
Intervention Type
Device
Intervention Name(s)
Contour NextOne
Intervention Description
A Standard of Care Glucometer with Bluetooth capability. The patient inserts a test strip into the device, takes a finger stick and collects a small blood sample on the tip of the strip to initiate the device to detect a glucose reading.
Primary Outcome Measure Information:
Title
HbA1c Variation
Description
Coefficient of variation in HbA1c levels before, during and end of study completion.
Time Frame
6 months
Title
HbA1c Range
Description
Variation of range in HbA1c levels before, during and end of study completion.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Current Diabetes Standards
Description
Current HEDIS performance on diabetes and behavioral health measures.
Time Frame
6 months
Title
Behavioral Changes
Description
Subjects will complete a self reported survey related to behavioral changes at end of study to assess self empowered behavioral changes after using the devices (e.g. feeling more empowered to self-manage care, engaged with changing healthcare behaviors, and patient perceptions of the technology).
Time Frame
6 months
Title
Hypoglycemic Events
Description
Frequency of hypoglycemic events during the study.
Time Frame
6 months
Title
Healthcare Utilization
Description
Healthcare utilization per count of inpatient/outpatient visits.
Time Frame
6 months
Title
Glycemic Variability
Description
Glycemic variability per mean amplitude of glycemic excursion (MAGE)
Time Frame
6 months
Title
Emergency Room Visits
Description
Emergency department visits per 1000 rate, overall and for patients with diabetes, and hospitalization per 1000 rate related to.
Time Frame
6 months
Title
Healthcare Cost
Description
Cost per patient of healthcare for Emergency Room visits, blood draws, inpatient/outpatient services, medications etc.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 1 or type 2 diabetes mellitus with a HbA1c ≥6.5% Patients that are currently managing their glucose levels for diabetes with a glucose meter (or will be prescribed one by their healthcare provider) Patients that are treated within the four Reimagine Primary Care clinics (Cottonwood Family Medicine, Cottonwood Senior, Avenues Internal Medicine, and Holladay Internal Medicine). • Patients 18-80 years of age Exclusion Criteria: Patients that are not managing their glucose levels for diabetes (and not advised to use a glucose monitor by their physician) Patients that are not treated within the four Reimagine Primary Care clinics Patients less than 18 years of age, and 81 years of age and older Patients with a diagnosis of dementia If the patient is currently using a Continuous Glucose Monitor Patients with previous hospitalization for hypoglycemia within the last 18 months No access to a mobile phone to download the Dexcom or Contour Next applications Patients who are pregnant or planning to become pregnant over the course of their six-month participation
Facility Information:
Facility Name
Holladay Internal Medicine
City
Holladay
State/Province
Utah
ZIP/Postal Code
84121
Country
United States
Facility Name
Intermountain Cottonwood Family Practice
City
Murray
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Facility Name
Intermountain Senior Clinic
City
Murray
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Facility Name
Avenues Internal Medicine
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84103
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29940936
Citation
Lee PA, Greenfield G, Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomised controlled trials. BMC Health Serv Res. 2018 Jun 26;18(1):495. doi: 10.1186/s12913-018-3274-8.
Results Reference
result
PubMed Identifier
23074529
Citation
Medical Advisory Secretariat. Home telemonitoring for type 2 diabetes: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9(24):1-38. Epub 2009 Oct 1.
Results Reference
result
PubMed Identifier
27697848
Citation
Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K, Radocchia LG, Esmaeili A, Sinha M, Russell SJ. Comparative Accuracy of 17 Point-of-Care Glucose Meters. J Diabetes Sci Technol. 2017 May;11(3):558-566. doi: 10.1177/1932296816672237. Epub 2016 Oct 3.
Results Reference
result
PubMed Identifier
28197954
Citation
Verkuilen J. Explanatory Item Response Models: A Generalized Linear and Nonlinear Approach by P. de Boeck and M. Wilson and Generalized Latent Variable Modeling: Multilevel, Longitudinal and Structural Equation Models by A. Skrondal and S. Rabe-Hesketh. Psychometrika. 2006 Jun;71(2):415-418. doi: 10.1007/s11336-005-1333-7. No abstract available.
Results Reference
result
PubMed Identifier
19966070
Citation
Fong Y, Rue H, Wakefield J. Bayesian inference for generalized linear mixed models. Biostatistics. 2010 Jul;11(3):397-412. doi: 10.1093/biostatistics/kxp053. Epub 2009 Dec 4.
Results Reference
result
PubMed Identifier
23242683
Citation
Musio M, Sauleau EA, Augustin NH. Resources allocation in healthcare for cancer: a case study using generalised additive mixed models. Geospat Health. 2012 Nov;7(1):83-9. doi: 10.4081/gh.2012.107.
Results Reference
result
Links:
URL
http://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes
Description
What is Diabetes
URL
https://www.cdc.gov/diabetes/basics/prediabetes.html
Description
Preventing prediabetes
URL
http://professional.diabetes.org/diapro/glucose_calc
Description
Diabetes and glucose information

Learn more about this trial

CGM - Reimagine Primary Care

We'll reach out to this number within 24 hrs